SyneuRx
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7700 Irvine Center Dr Ste 800, Irvine, C...Phone Number
+886 226972629Website
www.syneurx.comRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About SyneuRx
SyneuRx was founded in 2013 with the goal of using scientific breakthroughs to develop novel CNS drugs for patients suffering from severe mental health disorders. The multi-national team is located in the U.S. and Taiwan. Prior to starting SyneuRx, Dr. Guochuan (Emil) Tsai, MD, PhD was a member of the faculty at Harvard Medical School and is now at the UCLA School of Medicine, Department of Psychiatry and Biobehavioral Sciences. SyneurRx and Pentarlandir are trademarks and registered trademarks, respectively, of SyneuRx International. All previous trademarks and registered trademarks previously cited are hereby recognized and acknowledged.Explore more
SyneuRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SyneuRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
SyneuRx, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on SyneuRx recently announced quarterly report
Click to see if SyneuRx had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if SyneuRx is spiking on competitors!
Funding: Get notified immidiatlly once SyneuRx has new funding data
Check if SyneuRx has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at SyneuRx
Product Launch: Get notified when SyneuRx launches new products
Recommended Actions
Find VP level buyers at SyneuRx
Find more new buyers
Company Profile Activity
Activity Insights
SyneuRx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SyneuRx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SyneuRx.
SyneuRx Tech Stack
A closer look at the technologies used by SyneuRx
See more technologies
SyneuRx News & Media
SyneuRx Reaches Target Enrollment in Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)
LOS ANGELES & NEW TAIPEI CITY, Taiwan--(BUSINESS WIRE)--SyneuRx™ International (TPEX:6575), a global biotech company focused on the development of new classes of drugs for COVID-19 and multiple major central nervous system disorders, today announced it has completed enrollment for its phase 2 clinical trial evaluating the efficacy and safety of SNB01 ('Pentarlandir'), a novel COVID-19 oral antiviral candidate. In preclinical studies, Pentarlandir demonstrated preliminary efficacy and an excelleSyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing
NEW TAIPEI CITY, Taiwan and TORRANCE, Calif., Nov. 19, 2021 /PRNewswire/ -- SyneuRx™ International, (Taipei Exchange, ticker ID TT6575, www.syneurx.com), a pioneering developer of novel CNS (Central Nervous System) and anti-viral pharmaceuticals, today announced that its investigational...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding SyneuRx
Sign Up For FreeTo access detailed company insights
SyneuRx was founded in 2013 with the goal of using scientific breakthroughs to develop novel CNS drugs for patients suffering from severe mental health disorders. The multi-national team is located in the U.S. and Taiwan. Prior to starting SyneuRx, Dr. Guochuan (Emil) Tsai, MD, PhD was a member of the faculty at Harvard Medical School and is now at... Read More
